150 related articles for article (PubMed ID: 11567829)
1. The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells.
Kim JS; Amorino GP; Pyo H; Cao Q; Price JO; Choy H
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):525-34. PubMed ID: 11567829
[TBL] [Abstract][Full Text] [Related]
2. Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells.
Kim JC; Kim JS; Saha D; Cao Q; Shyr Y; Choy H
Radiother Oncol; 2003 Sep; 68(3):305-13. PubMed ID: 13129641
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
Amorino GP; Hamilton VM; Choy H
Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
[TBL] [Abstract][Full Text] [Related]
4. Combination of taxanes with radiation: preclinical studies.
Milas L; Milas MM; Mason KA
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):12-26. PubMed ID: 10210536
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of radiation effects by combined docetaxel and flavopiridol treatment in lung cancer cells.
Kim JC; Saha D; Cao Q; Choy H
Radiother Oncol; 2004 May; 71(2):213-21. PubMed ID: 15110456
[TBL] [Abstract][Full Text] [Related]
6. Preclinical antitumor activity of two novel taxanes.
Rose WC; Fairchild C; Lee FY
Cancer Chemother Pharmacol; 2001; 47(2):97-105. PubMed ID: 11269747
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
8. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ).
Pradier O; Rave-Fränk M; Lehmann J; Lücke E; Boghun O; Hess CF; Schmidberger H
Int J Cancer; 2001 Mar; 91(6):840-5. PubMed ID: 11275989
[TBL] [Abstract][Full Text] [Related]
9. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7).
Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF
J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273
[TBL] [Abstract][Full Text] [Related]
10. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer.
Amorino GP; Hercules SK; Mohr PJ; Pyo H; Choy H
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):503-9. PubMed ID: 10802379
[TBL] [Abstract][Full Text] [Related]
12. [Association of taxanes and radiotherapy: preclinical and clinical studies].
Hennequin C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S95-105. PubMed ID: 15679254
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel and radiation as combined-modality therapy.
Kim ES; Khuri FR
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
Gallo D; Ferlini C; Distefano M; Cantelmo F; Gaggini C; Fattorossi A; Riva A; Bombardelli E; Proietti E; Mancuso S; Scambia G
Cancer Chemother Pharmacol; 2000; 45(2):127-32. PubMed ID: 10663627
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
Bellon JR; Lindsley KL; Ellis GK; Gralow JR; Livingston RB; Austin Seymour MM
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):393-7. PubMed ID: 10974452
[TBL] [Abstract][Full Text] [Related]
16. The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo.
Shi B; Yaremko B; Hajian G; Terracina G; Bishop WR; Liu M; Nielsen LL
Cancer Chemother Pharmacol; 2000; 46(5):387-93. PubMed ID: 11127943
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Milas L; Saito Y; Hunter N; Milross CG; Mason KA
Radiother Oncol; 1996 Aug; 40(2):163-70. PubMed ID: 8884971
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer.
Edelstein MP; Wolfe LA; Duch DS
Semin Oncol; 1996 Apr; 23(2 Suppl 5):41-7. PubMed ID: 8610236
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.
Gupta N; Hu LJ; Deen DF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):885-95. PubMed ID: 9128966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]